FDA Approval Activities for this Drug… Ellence (epirubicin hydrochloride) Injection, 50 mg/25 mL & 200 mg/100 mL single-use vials, Pharmacia & Upjohn NDA 50-778/S3 & S4 4/3/03 4/18/03 Ellence (epirubicin hydrochloride), 50 mg/25 mL & 200 mg/100 mL single-use vials; Intravenous, Pharmacia & Upjohn NDA 50-778 9/15/99 9/24/99 9/24/99 1/30/03 Ellence Indication: Indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer. | Ellence (epirubicin hydrochloride) injection, Pfizer, Efficacy Supplement w/Clinical Data to Support Back to this API's Main Page.

Browse other API's patent/exclusivity pages… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Find API by Brand Name | Industry Information | Prescription Drug Websites | Search | Site Map         © 2009 Betterchem.com